Amalgamated Bank’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
5,744
-1,521
| -21% | -$40.2K | ﹤0.01% | 1620 |
|
|
2025
Q1 | $175K | Buy |
7,265
+265
| +4% | +$6.38K | ﹤0.01% | 1560 |
|
|
2024
Q4 | $282K | Hold |
7,000
| – | – | ﹤0.01% | 1484 |
|
|
2024
Q3 | $443K | Sell |
7,000
-35
| -0.5% | -$2.22K | ﹤0.01% | 1344 |
|
|
2024
Q2 | $373K | Buy |
7,035
+3,578
| +104% | +$190K | ﹤0.01% | 1407 |
|
|
2024
Q1 | $283K | Sell |
3,457
-10,156
| -75% | -$831K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $253K | Sell |
13,613
-965
| -7% | -$17.9K | ﹤0.01% | 1722 |
|
|
2023
Q3 | $161K | Hold |
14,578
| – | – | ﹤0.01% | 1853 |
|
|
2023
Q2 | $236K | Buy |
+14,578
| New | +$236K | ﹤0.01% | 1761 |
|
|
2022
Q2 | – | Sell |
-8,272
| Closed | -$25K | – | 3209 |
|
|
2022
Q1 | $25K | Buy |
+8,272
| New | +$25K | ﹤0.01% | 2737 |
|
|
2020
Q2 | – | Sell |
-10,082
| Closed | -$47K | – | 1654 |
|
|
2020
Q1 | $47K | Sell |
10,082
-380
| -4% | -$1.77K | ﹤0.01% | 1577 |
|
|
2019
Q4 | $84K | Buy |
+10,462
| New | +$84K | ﹤0.01% | 1751 |
|